Belief Biomed (beijing) Co., Ltd

This early-stage study tests a gene therapy called BBM-D101 in 9 boys aged 4 to 8 with Duchenne muscular dystrophy (DMD). The goal is to see if it is safe and can help produce a missing protein in muscles. Researchers will monitor side effects and measure changes in muscle health…

This early-stage study tests a new gene therapy called BBM-A101 for people with moderate knee osteoarthritis. The main goal is to check if it is safe and tolerable. About 81 adults with knee pain and joint changes will receive the treatment and be monitored for side effects and a…